Global Embolotherapy Market, By Product (Embolic Agents and Support Devices), Disease Indication (Cancer, Peripheral Vascular Disease, Neurological Diseases, Urological and Nephrological Disorders and Gastrointestinal Disorders), Procedure (Trans catheter Arterial Embolization (TAE), Trans catheter Arterial Radio embolization (TARE)/ Selective Internal Radiation Therapy (SIRT) and Trans arterial Chemoembolization), End User (Hospitals and Clinics, Ambulatory Surgery Centres and Other End Users), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028.
Market Analysis and Insights of Embolotherapy Market
Data Bridge Market Research analyses that the embolotherapy market will exhibit a CAGR of around 8.00% for the forecast period of 2021-2028. Increasing application of embolization devices, increased focus of the manufacturers on technological advancements and rising expenditure on the improvement of healthcare infrastructure especially in the developing economies are the major factors attributable to the growth of embolotherapy market.
Embolotherapy is a minimally invasive surgical procedure to prevent and control haemorrhaging. Embolotherapy is a surgical procedure wherein the arteries are blocked with the help of inserting coils, balloons and others to treat bleeding ulcers and blood vessel defects as well.
Growing prevalence of hepatocellular cancer and liver cancer coupled with increased focus of the major manufacturers on technological advancements will propel the growth in the demand for embolotherapy. Rising expenditure to develop healthcare infrastructure coupled with rising research and development proficiencies to make advancements in the healthcare technology will further propel growth in the embolotherapy market value. Increasing patient preference for minimally invasive procedures and increasing personal disposable income are some other market growth determinants.
However, dearth of skilled professionals especially in the developing economies will challenge the growth of market in the forecast period mentioned above. Strong market positioning of alternative therapies will obstruct the market growth rate. The strict regulatory structure for product approval and commercialization will also derail the market growth rate.
This embolotherapy market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on embolotherapy market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Embolotherapy Market Scope and Market Size
The embolotherapy market is segmented on the basis of product, disease indication, procedure and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of product, the embolotherapy market is segmented into embolic agents and support devices. Embolic agents segment is sub-segmented into microspheres, embolic coils, liquid embolic agents, embolic plug systems and detachable balloons. Embolic coils market is further bifurcated into push able coils and detachable coils. Support devices segment is sub-segmented into micro catheters and guide wires.
- On the basis of disease indication, the embolotherapy market is segmented into cancer, peripheral vascular disease, neurological diseases, urological and nephrological disorders and gastrointestinal disorders. Cancer segment is sub-segmented into liver cancer, kidney cancer and others. Neurological diseases segment is sub-segmented into cerebral aneurysm and arteriovenous malformation and fistulas.
- On the basis of procedure, the embolotherapy market is segmented into trans catheter arterial embolization (TAE), trans catheter arterial radio embolization (TARE)/ selective internal radiation therapy (SIRT) and trans arterial chemoembolization.
- On the basis of end user, the embolotherapy market is segmented hospitals and clinics, ambulatory surgery centres and other end users.
Embolotherapy Market Country Level Analysis
The embolotherapy market is analysed and market size insights and trends are provided by product, disease indication, procedure and end user as referenced above.
The countries covered in the embolotherapy market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the embolotherapy market owing to the prevalence of favourable reimbursement policies coupled with existence of major players. Prevalence of sophisticated technological healthcare facilities will also drive the market growth in this region. Asia-Pacific on the other hand will score the highest growth rate during the forecast period owing to booming medical tourism, developing healthcare network and increasing research and development activities.
The country section of the embolotherapy market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The embolotherapy market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for digital health technologies market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the embolotherapy market. The data is available for historic period 2010 to 2019.
Competitive Landscape and Embolotherapy Market Share Analysis
The embolotherapy market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to embolotherapy market.
The major players covered in the embolotherapy market report are Terumo Corporation, Merit Medical Systems, Inc., Simbionix USA Corporation., Cook, Boston Scientific Corporation, Penumbra, Inc., Meril Life Sciences Pvt. Ltd., Medtronic, BTG International Limited, ABK Biomedical, Abbott, AngioDynamics, IMBIOTECHNOLOGIES LTD., Debakey Medlife Private Limited, Heraeus Holding, Guerbet, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., and BD among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-